共 50 条
- [22] Health impact of tafamidis in transthyretin amyloid cardiomyopathy patients: an analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the open-label long-term extension studies EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2022, 8 (05) : 529 - 538
- [24] Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy Journal of Neurology, 2013, 260 : 2802 - 2814
- [28] Long- term tafamidis efficacy in patients with transthyretin amyloid cardiomyopathy by baseline left ventricular ejection fraction AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S4 - S4